Age of onset of mental disorders: a review of recent literature

Purpose of review The aim of this article is to review recent epidemiological research on age-of-onset of mental disorders, focusing on the WHO World Mental Health surveys. Recent findings Median and inter-quartile range (IQR; 25th–75th percentiles) of age-of-onset is much earlier for phobias (7–14, IQR 4–20) and impulse–control disorders (7–15; IQR 4–35) than other anxiety disorders (25–53, IQR 15–75), mood disorders (25–45, IQR 17–65), and substance disorders (18–29, IQR 16–43). Although less data exist for nonaffective psychosis, available evidence suggests that median age-of-onset is in the range late teens through early 20s. Roughly half of all lifetime mental disorders in most studies start by the mid-teens and three quarters by the mid-20s. Later onsets are mostly secondary conditions. Severe disorders are typically preceded by less severe disorders that are seldom brought to clinical attention. Summary First onset of mental disorders usually occur in childhood or adolescence, although treatment typically does not occur until a number of years later. Although interventions with early incipient disorders might help reduce severity-persistence of primary disorders and prevent secondary disorders, additional research is needed on appropriate treatments for early incipient cases and on long-term evaluation of the effects of early intervention on secondary prevention.

[1]  T. B. Üstün,et al.  The WHO World Mental Health (WMH) Surveys , 2009, Die Psychiatrie.

[2]  D. Bylund,et al.  Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. , 2007, Biochemical pharmacology.

[3]  J. Veijola,et al.  Outcome and its predictors in schizophrenia - The northern Finland 1966 birth cohort , 2007, European Psychiatry.

[4]  J. Suvisaari,et al.  Lifetime prevalence of psychotic and bipolar I disorders in a general population. , 2007, Archives of general psychiatry.

[5]  Fausto Mazzi,et al.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys , 2006, International journal of methods in psychiatric research.

[6]  M. Lambert,et al.  Treated incidence of first‐episode psychosis in the catchment area of EPPIC between 1997 and 2000 , 2006, Acta psychiatrica Scandinavica.

[7]  R. Kessler,et al.  Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China , 2006, Psychological Medicine.

[8]  M. McGee,et al.  Lifetime Prevalence and Projected Lifetime Risk of DSM-IV Disorders in Te Rau Hinengaro: The New Zealand Mental Health Survey , 2006, The Australian and New Zealand journal of psychiatry.

[9]  P. Morosini,et al.  Prevalence of common mental disorders in Italy , 2006, Social Psychiatry and Psychiatric Epidemiology.

[10]  F Berrino,et al.  Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition , 2006, British Journal of Cancer.

[11]  R. Kessler,et al.  The World Health Organization World Mental Health Survey Initiative , 2006, Epidemiologia e Psichiatria Sociale.

[12]  D. Clark,et al.  Substance use disorder trajectory classes: diachronic integration of onset age, severity, and course. , 2006, Addictive behaviors.

[13]  A. Yung,et al.  Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals , 2006, Schizophrenia Research.

[14]  O. Gureje,et al.  Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being , 2006, British Journal of Psychiatry.

[15]  K. Matthews,et al.  Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study. , 2006, JAMA.

[16]  Josep Maria Haro,et al.  Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-España , 2006 .

[17]  T. J. Morgan,et al.  Evaluating two brief substance-use interventions for mandated college students. , 2006, Journal of studies on alcohol.

[18]  G. de Girolamo,et al.  Prevalence of common mental disorders in Italy: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). , 2006, Social psychiatry and psychiatric epidemiology.

[19]  J. Haro,et al.  [Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study]. , 2006, Medicina clinica.

[20]  A. Yung,et al.  Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States , 2005 .

[21]  Olga V. Demler,et al.  The Prevalence and Correlates of Nonaffective Psychosis in the National Comorbidity Survey Replication (NCS-R) , 2005, Biological Psychiatry.

[22]  Georg Juckel,et al.  The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. , 2005, World psychiatry : official journal of the World Psychiatric Association.

[23]  J. Schwartz,et al.  Epidemiology of psychiatric and alcohol disorders in Ukraine , 2005, Social Psychiatry and Psychiatric Epidemiology.

[24]  M. Medina-Mora,et al.  Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey , 2005, Psychological Medicine.

[25]  W. Iacono,et al.  The association of early adolescent problem behavior with adult psychopathology. , 2005, The American journal of psychiatry.

[26]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[27]  T. B. Üstün,et al.  The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) , 2004, International journal of methods in psychiatric research.

[28]  A. Nierenberg,et al.  Placebo-Controlled Continuation Treatment with Mirtazapine: Acute Pattern of Response Predicts Relapse , 2004, Neuropsychopharmacology.

[29]  M. Höfler,et al.  Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS) , 2004, Psychological Medicine.

[30]  L. Phillips,et al.  The initial prodrome to bipolar affective disorder: prospective case studies. , 2003, Journal of affective disorders.

[31]  R. Krueger,et al.  A cross-cultural study of the structure of comorbidity among common psychopathological syndromes in the general health care setting. , 2003, Journal of abnormal psychology.

[32]  R. Kessler,et al.  The impact of childhood psychopathology interventions on subsequent substance abuse: policy implications, comments, and recommendations. , 2002, Journal of consulting and clinical psychology.

[33]  M. Corcos,et al.  [Epidemiology and natural history of schizophrenia]. , 2002, La Revue du praticien.

[34]  A. Malla,et al.  Duration of untreated psychosis: a critical examination of the concept and its importance , 2001, Psychological Medicine.

[35]  R. Kessler,et al.  The epidemiology of generalized anxiety disorder. , 2001, The Psychiatric clinics of North America.

[36]  J. Kagan,et al.  A controlled study of behavioral inhibition in children of parents with panic disorder and depression. , 2000, The American journal of psychiatry.

[37]  R. Loeber,et al.  Oppositional defiant and conduct disorder: a review of the past 10 years, part I. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[38]  L. Scahill,et al.  Epidemiology of ADHD in school-age children. , 2000, Child and adolescent psychiatric clinics of North America.

[39]  P L Morselli,et al.  Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups , 2000, Psychological Medicine.

[40]  Olga V. Demler,et al.  Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. , 2000, Bulletin of the World Health Organization.

[41]  R. Kessler,et al.  Improving accuracy of major depression age‐of‐onset reports in the US National Comorbidity Survey , 1999 .

[42]  R. Kessler,et al.  The World Health Organization Composite International Diagnostic Interview short‐form (CIDI‐SF) , 1998 .

[43]  R. Kessler The prevalence of psychiatric comorbidity. , 1997 .

[44]  P. Thomsen Schizophrenia with childhood and adolescent onset — a nationwide register‐based study , 1996, Acta psychiatrica Scandinavica.

[45]  G. Simon,et al.  Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research. , 1995, Epidemiologic reviews.

[46]  M Marmot,et al.  Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort , 1994, The Lancet.

[47]  Shivalingappa S. Halli,et al.  Advanced techniques of population analysis , 1992 .

[48]  D S Rae,et al.  Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults. , 1988, The American journal of psychiatry.

[49]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .